Searching for a Cure: The FDA's Regulatory Approach to Traditional Chinese Herbal Medicine

Searching for a Cure: The FDA's Regulatory Approach to Traditional Chinese Herbal Medicine

DSpace/Manakin Repository

Searching for a Cure: The FDA's Regulatory Approach to Traditional Chinese Herbal Medicine

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Kim, Anna L.
dc.date.accessioned	2012-08-17T14:51:25Z
dc.date.issued	1997
dc.identifier.citation	Searching for a Cure: The FDA's Regulatory Approach to Traditional Chinese Herbal Medicine (1997 Third Year Paper)	en_US
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:9414574
dc.description.abstract	I will begin this discussion by describing traditional Chinese medicine and how it compares to the Western medical tradition. Second, I will then examine why regulation is necessary given the impact of Chinese herbal medicine on American healthcare. Then, I will proceed to the problem of trying to fit a square peg into a round hole, namely, the issue of regulating Chinese herbal medicine under current statutory provisions. Fourth, I will analyze state and federal responses to alternative therapies in general and Chinese herbal medicine in particular, afterwards focusing on the FDA's piecemeal approach thus far. Finally, I will examine two potential models for reform, Germany and Canada, to see if there are lessons to be leamed from their practices.	en_US
dc.language.iso	en_US	en
dash.license	LAA
dc.subject	Food and Drug Law	en_US
dc.subject	traditional chinese medicine	en_US
dc.subject	human drugs	en_US
dc.subject	FDA	en_US
dc.subject	alternative medicine	en_US
dc.title	Searching for a Cure: The FDA's Regulatory Approach to Traditional Chinese Herbal Medicine	en_US
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-08-17T14:51:25Z